+39 050 3154101
Via Meucci, n° 36, 56121 Pisa - Loc. Ospedaletto (Italy)
 

Abiogen focuses its activity on Licensing In in order to ensure dynamic development of the company through the identification and realization of business opportunities.
Abiogen Pharma’s entrepreneurial commitment and the resulting prospects are aimed at exploring strategic partnerships that can advance the product portfolio in therapeutic areas such as the musculoskeletal area, pediatrics, dermatology and the respiratory area.

Our partnerships

USA

Anika Therapeutics

https://www.abiogen.it/wp-content/uploads/2023/07/logo-anika-min-1.jpg

Acido Ialuronico Cross-linkato / Cingal

SWITZERLAND

Om Pharma

https://www.abiogen.it/wp-content/uploads/2023/07/logo-ohm-pharma-min-1.jpg

Lisato Batterico Liofilizzato / Broncho Munal

SPAIN

Almirall
Aceclofenac / Gladio

ImasMed

https://www.abiogen.it/wp-content/uploads/2023/07/logo-i-med-min.jpg

Acido Ialuronico Cross-linkato / Jonexa Up

JAPAN

Hisamitsu Pharmaceutical CO0.INC.

https://www.abiogen.it/wp-content/uploads/2023/07/logo-hisamitsu-min.jpg

Ketoprofene cerotto medicato / Keplat

ITALY

Organon Italia S.r.l.

Alendronato/Alendros

SWEDEN

Galenica AB

https://www.abiogen.it/wp-content/uploads/2023/07/logo-galenica-min.jpg

Mometasone Furoato-Ovixan Mometasone Furoato-Ovison

THE NETHERLANDS

Synthon B.V. (Microweg)

Etoricoxib / Quantico

TAIWAN

Bened Biomedical LTD

PS23 probiotico